Barclays initiated coverage of Marex Group with an Overweight rating and $25 price target. With “ample” growth opportunities, potential upside from acquisitions and high barriers to entry, the shares are attractively valued trading at just seven-times the firm’s fiscal 2025 earnings estimates, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MRX:
